Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.
Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.
Breast Cancer. 2021 Nov;28(6):1346-1357. doi: 10.1007/s12282-021-01275-4. Epub 2021 Jul 22.
Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined the proportion of patients who needed treatment for CPSP and associated predictors.
We conducted a cross-sectional study with female patients who underwent breast cancer surgery at our institution. Participants were aged ≤ 65 years at the time of this study and were at least 1 year post surgery. The questionnaire examined the presence of and need for treatment for CPSP and included the Japanese version of the Concerns about Recurrence Scale (CARS-J). Multivariate analyses were used to identify independent predictors of needing treatment for CPSP.
In total, 305 patients completed the questionnaire. The mean time since surgery was 67.1 months; 156 (51%) patients developed CPSP after breast cancer surgery and 61 (39%) needed treatment for CPSP. Among patients that developed CPSP, the fear of breast cancer recurrence as assessed by the CARS-J (odds ratio [OR] 2.59, 95% confidence interval [CI] 1.14-6.28, P = 0.028) and ≥ 2 postsurgical pain regions (OR 2.52, 95% CI 1.16-5.57, P = 0.020) were independent predictors of needing treatment for CPSP.
This study is the first to identify the proportion and predictors of patients who need treatment for CPSP. Fear of breast cancer recurrence and ≥ 2 postsurgical pain regions may predict the need for CPSP treatment among patients following breast cancer surgery.
尽管乳腺癌手术后慢性术后疼痛(CPSP)是一种常见且普遍的术后不良事件,但 CPSP 的治疗需求尚未得到调查。本研究调查了需要 CPSP 治疗的患者比例及其相关预测因素。
我们进行了一项横断面研究,纳入在我院接受乳腺癌手术的女性患者。参与者在本研究时年龄≤65 岁,且至少在手术后 1 年。问卷检查了 CPSP 的存在和治疗需求,并包括日本版的担忧复发量表(CARS-J)。使用多变量分析来确定需要 CPSP 治疗的独立预测因素。
共有 305 名患者完成了问卷。手术以来的平均时间为 67.1 个月;156 名(51%)患者在乳腺癌手术后出现 CPSP,61 名(39%)需要治疗 CPSP。在出现 CPSP 的患者中,CARS-J 评估的对乳腺癌复发的恐惧(比值比 [OR] 2.59,95%置信区间 [CI] 1.14-6.28,P=0.028)和≥2 个术后疼痛区域(OR 2.52,95% CI 1.16-5.57,P=0.020)是需要治疗 CPSP 的独立预测因素。
本研究首次确定了需要治疗 CPSP 的患者的比例和预测因素。对乳腺癌复发的恐惧和≥2 个术后疼痛区域可能预测乳腺癌手术后患者对 CPSP 治疗的需求。